Mark Zuckerberg and his wife Priscilla Chan have donated $25 million through their foundation to a philanthropic effort organized by Bill Gates to explore new coronavirus treatments. 

The Gates Foundation donated $50 million last week to what it’s calling the “COVID-19 Therapeutics Accelerator.” The initiative brings together life sciences companies to collaborate on the development of new vaccines, diagnostics, and treatments for COVID-19.

“The Therapeutics Accelerator will enable researchers to quickly determine whether or not existing drugs have a potential benefit against COVID-19,” Chan and Zuckerberg said in a press release. “We hope these coordinated efforts will help stop the spread of COVID-19 as well as provide shared, reusable strategies to respond to future pandemics.”

The two donations are the largest from tech billionaires since the coronavirus outbreak. Wellcome and Mastercard are supporting the effort as well. 

The goal of the initiative is to either develop a new drug or adapt an existing treatment that it could help distribute alongside partnering pharmaceutical companies. 

The 15 companies participating in the project kicked off the effort by sharing their proprietary libraries of molecular compounds that have some history of being tested with COVID-19. 

The lineup includes big names in biotech such as Johnson & Johnson, Merck, Pfizer, Sanofi, and Bristol-Myers Squibb. 

Share:
More In Technology
Disney Q3 Earnings Dragged Down by Slowing Subscriber Growth
Mike Proulx, VP and research director at Forrester, joined Cheddar to talk all about Disney's lackluster Q3 earnings after the company reported a slowdown in Disney+ subscriber growth. Proulx discussed a Forrester study that found 45 percent of U.S. adults subscribed to streaming services because of the pandemic but 26 percent had plans to cancel a service over the next two years. "We're always going to look at growth, and we also have to look at engagement," he said. "But both of those metrics come down to having either original or exclusive content that will offer value to the subscriber base."
Rivian's Stellar IPO a Good Sign for Growing EV Market
Anthony Sassine, a senior investment strategist at KraneShares, joined Cheddar to discuss Rivian's historic public debut after the company achieved an $86 billion valuation — more than either Ford or GM. He said the big IPO was a great opportunity for the U.S. to position itself as a leader in the EV space after lagging behind Europe and China. "When you have certainty for growth for the next 10 to 15 years, investors are willing to pay more," he said. "So, this is a massive opportunity for the whole space."
Load More